SunPower Corp. (Nasdaq: SPWR) announced today that the third-generation SunPower® Oasis® platform for large-scale solar power plants, featuring a seamless integration of hardware and software unprecedented in the solar industry, is launching at an event today at SunPower’s new research and development facility in Davis, Calif.
“The Oasis platform is a complete solution that optimizes energy production and maximizes value for our power plant customers,” said Tom Werner, president and CEO of SunPower. “Integral to each Oasis component, from the automated design tools to robotic panel cleaning, is more than 30 years of solar industry innovation and experience that only SunPower offers, enabling our customers to benefit from the world’s most efficient, reliable solar technology available.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7706153-sunpower-oasis/
Following the successful integration of eyeshadow try-on earlier this spring, Sephora, the leader in global prestige beauty retail, continues to drive mobile engagement with the launch of even more augmented reality-based features to Sephora Virtual Artist on its award-winning iOS and Android apps. New today are Cheek Try On, which allows users to virtually try on over 1,000 shades of cheek color, an expanded library of Looks, and a Color Match for Virtual Try On feature, which uses Artificial Intelligence to detect and accurately estimate the shade in any photo and match it with a lip, eyeshadow or cheek products available at Sephora. Available in the Sephora app, these new features for Sephora Virtual Artist are the latest in a series of digital enhancements powered by the Sephora Innovation Lab to customize the retailer’s expanding beauty experiences.
To view the multimedia release go to:
https://www.multivu.com/players/English/7926154-sephora-virtual-artist-cheek-try-on-color-match/
BloodCenter of Wisconsin’s Diagnostic Laboratories, part of Versiti, today announced the launch of seven hematology genetics test panels. The new test panels enhance and expand BloodCenter’s genetic testing capability to include a vast array of non-malignant hematology disorders, including platelet function disorders, inherited thrombocytopenia and congenital neutropenias, providing one of the most comprehensive test menus in hematology.
BloodCenter’s integration of functional and genetic testing provides a unique approach to diagnosing complex hematology disorders, providing a comprehensive review of each patient for improved patient care and outcomes.
To view the multimedia release go to:
https://www.multivu.com/players/English/8126851-bloodcenter-of-wisconsin-versiti-hematology-genetics-test-panels/
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, will launch its latest advancement in comprehensive medication management, BD HealthSight™ platform for enterprise medication management, which offers a unique combination of connective technologies, analytics and expert services at this year's American Society of Health-System Pharmacists (ASHP) 2017 Midyear Meeting being held in Orlando from Dec. 3-7.
With direct medical costs associated with medication errors reaching $21 billion worldwide, innovative strategies must be developed to address the grand health challenges associated with medication management. BD has been evolving its focus to re-invent medication management with integration of the company’s technologies, analytics and expert services that aim to close the communication gaps across disparate solutions. The BD HealthSight platform connects systems and processes to help hospitals and health systems drive a safer, more efficient medication management process.
To view the multimedia release go to:
https://www.multivu.com/players/English/8198551-bd-healthsight-platform-ashp-2017/
